Quick Answer
Telomir Pharmaceuticals, Inc. reported Shares Outstanding of 34.38 million shares for fiscal year 2025.
Telomir Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 34.38M | +15.5% |
| 2024 | 29.76M | +4.0% |
| 2023 | 28.61M | +6.6% |
| 2022 | 26.83M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 33.83M | +14.3% | +10.9% |
| June 30, 2025 | 30.51M | +3.1% | +2.5% |
| March 31, 2025 | 29.76M | +0.5% | +0.0% |
| December 31, 2024 | 29.76M | +4.0% | +0.5% |
| September 30, 2024 | 29.61M | — | +0.0% |
| June 30, 2024 | 29.61M | — | +0.0% |
| March 31, 2024 | 29.61M | — | +3.5% |
| December 31, 2023 | 28.61M | — | — |
- Telomir Pharmaceuticals, Inc. showed an increase of +15.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Telomir Pharmaceuticals, Inc.’s shares outstanding has grown by 28.1% (from 26.83 million shares to 34.38 million shares).
- The most recent figure is from Telomir Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: